BioLine RX (Israel) Price History

BLRX Stock  ILS 2.10  0.10  5.00%   
If you're considering investing in BioLine Stock, it is important to understand the factors that can impact its price. As of today, the current price of BioLine RX stands at 2.10, as last reported on the 26th of March, with the highest price reaching 2.20 and the lowest price hitting 2.00 during the day. BioLine RX secures Sharpe Ratio (or Efficiency) of -0.24, which signifies that the company had a -0.24 % return per unit of risk over the last 3 months. BioLine RX exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLine RX's Standard Deviation of 7.7, risk adjusted performance of (0.18), and Mean Deviation of 5.38 to double-check the risk estimate we provide.
  
BioLine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2407

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBLRX

Estimated Market Risk

 8.21
  actual daily
73
73% of assets are less volatile

Expected Return

 -1.98
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.24
  actual daily
0
Most of other assets perform better
Based on monthly moving average BioLine RX is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioLine RX by adding BioLine RX to a well-diversified portfolio.

BioLine RX Stock Price History Chart

There are several ways to analyze BioLine Stock price data. The simplest method is using a basic BioLine candlestick price chart, which shows BioLine RX price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 9, 20247.5
Lowest PriceMarch 4, 20251.8

BioLine RX March 26, 2025 Stock Price Synopsis

Various analyses of BioLine RX's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BioLine Stock. It can be used to describe the percentage change in the price of BioLine RX from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BioLine Stock.
BioLine RX Accumulation Distribution 28,545 
BioLine RX Price Daily Balance Of Power 0.50 
BioLine RX Price Rate Of Daily Change 1.05 
BioLine RX Price Action Indicator 0.05 

BioLine RX March 26, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in BioLine Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use BioLine RX intraday prices and daily technical indicators to check the level of noise trading in BioLine Stock and then apply it to test your longer-term investment strategies against BioLine.

BioLine Stock Price History Data

The price series of BioLine RX for the period between Thu, Dec 26, 2024 and Wed, Mar 26, 2025 has a statistical range of 6.3 with a coefficient of variation of 53.65. The prices are distributed with arithmetic mean of 4.02. The median price for the last 90 days is 3.5. The company had 1:10 stock split on 7th of June 2015.
OpenHighLowCloseVolume
03/25/2025 2.20  2.20  2.00  2.10  314,000 
03/24/2025 2.10  2.20  2.10  2.10  4,689,659 
03/20/2025 2.00  2.10  2.00  2.00  2,263,602 
03/19/2025 2.00  2.00  1.90  2.00  9,154,223 
03/18/2025 2.00  2.10  1.90  2.00  10,812,100 
03/17/2025 2.00  2.00  1.90  2.00  834,200 
03/13/2025 2.00  2.00  1.90  2.00  4,287,966 
03/12/2025 2.00  2.00  1.90  1.90  1,845,135 
03/11/2025 2.00  2.00  1.90  2.00  11,786,103 
03/10/2025 2.10  2.10  1.90  1.90  2,739,453 
03/06/2025 2.00  2.10  1.90  1.90  3,932,621 
03/05/2025 1.90  2.00  1.90  2.00  4,030,053 
03/04/2025 2.00  2.00  1.80  1.80  18,281,913 
03/03/2025 2.00  2.10  2.00  2.00  15,829,174 
02/27/2025 2.10  2.20  2.00  2.00  8,052,350 
02/26/2025 2.20  2.20  2.10  2.10  11,734,048 
02/25/2025 2.10  2.30  2.10  2.20  2,624,601 
02/24/2025 2.20  2.30  2.10  2.10  4,777,545 
02/20/2025 2.40  2.40  2.30  2.30  11,772,351 
02/19/2025 2.40  2.50  2.40  2.40  7,649,766 
02/18/2025 2.60  2.60  2.20  2.20  39,947,223 
02/17/2025 2.30  2.70  2.30  2.60  23,555,139 
02/13/2025 2.10  2.20  2.00  2.10  4,955,911 
02/12/2025 2.10  2.10  2.00  2.00  11,988,219 
02/11/2025 2.00  2.10  2.00  2.00  10,898,522 
02/10/2025 2.10  2.10  2.00  2.00  14,044,131 
02/06/2025 2.10  2.20  2.10  2.10  6,125,886 
02/05/2025 2.10  2.20  2.00  2.20  10,711,685 
02/04/2025 2.10  2.20  2.00  2.10  20,196,358 
02/03/2025 2.30  2.30  2.20  2.20  25,512,727 
01/30/2025 2.80  3.00  2.40  2.40  65,346,387 
01/29/2025 3.30  3.50  3.10  3.20  67,338,864 
01/28/2025 3.50  3.70  3.50  3.60  9,157,643 
01/27/2025 3.60  3.70  3.50  3.50  8,775,033 
01/23/2025 3.70  3.80  3.60  3.70  12,682,541 
01/22/2025 3.80  3.90  3.50  3.50  19,111,698 
01/21/2025 4.00  4.10  3.60  3.70  30,063,529 
01/20/2025 3.80  4.00  3.80  4.00  6,585,933 
01/16/2025 3.80  4.70  3.60  3.80  57,312,660 
01/15/2025 4.20  4.40  4.00  4.10  25,507,782 
01/14/2025 4.60  4.80  4.40  4.40  17,799,771 
01/13/2025 5.20  5.30  4.50  4.50  18,555,882 
01/09/2025 4.70  5.00  4.70  4.80  6,624,823 
01/08/2025 5.10  5.30  4.60  4.80  20,497,643 
01/07/2025 5.20  5.50  5.00  5.00  25,480,858 
01/06/2025 7.60  7.90  5.00  5.30  41,521,765 
01/02/2025 6.80  7.10  6.70  7.10  3,361,221 
12/31/2024 6.40  6.70  6.30  6.40  2,631,218 
12/30/2024 6.50  6.90  6.30  6.40  1,732,119 
12/26/2024 6.70  7.00  6.60  6.80  3,221,416 
12/25/2024 6.70  7.00  6.60  6.70  3,266,450 
12/24/2024 6.60  7.00  6.50  6.90  7,419,969 
12/23/2024 7.00  7.20  6.40  6.70  7,190,075 
12/19/2024 5.30  5.90  5.30  5.70  2,761,339 
12/18/2024 5.80  6.00  5.60  5.80  6,565,810 
12/17/2024 6.30  6.50  6.10  6.30  4,175,658 
12/16/2024 6.70  6.90  6.30  6.50  4,389,515 
12/12/2024 7.00  7.20  6.80  6.90  4,362,464 
12/11/2024 7.20  7.60  6.90  7.00  3,807,758 
12/10/2024 7.20  7.50  7.00  7.10  2,249,463 
12/09/2024 7.60  7.90  7.20  7.50  2,916,996 

About BioLine RX Stock history

BioLine RX investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioLine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioLine RX will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioLine RX stock prices may prove useful in developing a viable investing in BioLine RX
BioLineRx Ltd., a clinical stage biopharmaceutical development company, focuses on oncology and immunology. BioLineRx Ltd. was founded in 2003 and is based in Modiin, Israel. BIOLINE RX operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 48 people.

BioLine RX Stock Technical Analysis

BioLine RX technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BioLine RX technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BioLine RX trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

BioLine RX Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for BioLine RX's price direction in advance. Along with the technical and fundamental analysis of BioLine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioLine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for BioLine Stock analysis

When running BioLine RX's price analysis, check to measure BioLine RX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLine RX is operating at the current time. Most of BioLine RX's value examination focuses on studying past and present price action to predict the probability of BioLine RX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLine RX's price. Additionally, you may evaluate how the addition of BioLine RX to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account